Withdrawing FDA Approval of Midodrine After Marketing

被引:2
|
作者
Holtzman, Neil A. [1 ]
Starfield, Barbara [1 ]
机构
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源
关键词
D O I
10.1001/jama.2011.161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:781 / 782
页数:2
相关论文
共 50 条
  • [21] FDA Approval for Vectical
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (05) : 497 - 497
  • [22] FDA APPROVAL IS NOT A SHIELD
    Hess, Glenn
    [J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (23) : 12 - 12
  • [23] FDA Approval: Blinatumomab
    Przepiorka, Donna
    Ko, Chia-Wen
    Deisseroth, Albert
    Yancey, Carolyn L.
    Candau-Chacon, Reyes
    Chiu, Haw-Jyh
    Gehrke, Brenda J.
    Gomez-Broughton, Candace
    Kane, Robert C.
    Kirshner, Susan
    Mehrotra, Nitin
    Ricks, Tiffany K.
    Schmiel, Deborah
    Song, Pengfei
    Zhao, Ping
    Zhou, Qing
    Farrell, Ann T.
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4035 - 4039
  • [24] FDA and drug approval
    Faich, GA
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S24 - S24
  • [25] FDA Approval of Ipilimumab
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (05) : 552 - 552
  • [26] FDA ALENDRONATE APPROVAL
    MCCARTHY, M
    [J]. LANCET, 1995, 346 (8981): : 1028 - 1028
  • [27] FDA Approval for Golimumab
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [28] FDA Approval for Rectiv
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (08) : 939 - 939
  • [29] THE FDA APPROVAL PROCESS
    HOKE, F
    [J]. SCIENTIST, 1994, 8 (18): : 6 - 6
  • [30] FDA approval likely
    不详
    [J]. EUROPEAN CHEMICAL NEWS, 1996, 66 (1741): : 52 - 52